These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 35063799)

  • 1. Hepatitis C virus and kidney transplantation: Recent trends and paradigm shifts.
    El Helou G; Jay C; Nunez M
    Transplant Rev (Orlando); 2022 Jan; 36(1):100677. PubMed ID: 35063799
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A review of kidney transplantation from HCV-viremic donors into HCV-negative recipients.
    Daloul R; Pesavento TE; Goldberg DS; Reese PP
    Kidney Int; 2021 Dec; 100(6):1190-1198. PubMed ID: 34237327
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Kidney Transplantation From Hepatitis C Virus-Infected Donors to Uninfected Recipients: A Systematic Review for the KDIGO 2022 Hepatitis C Clinical Practice Guideline Update.
    Gordon CE; Adam GP; Jadoul M; Martin P; Balk EM
    Am J Kidney Dis; 2023 Oct; 82(4):410-418. PubMed ID: 37061019
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of Donor Hepatitis C Virus on Kidney Transplant Outcomes for Hepatitis C-positive Recipients in the Direct-acting Antiviral Era: Time to Revise the Kidney Donor Risk Index?
    Cannon RM; Locke JE; Orandi BJ; Anderson DJ; Davis EG; Mackelaite L; Dave H; Eng M; Jones CM
    Transplantation; 2020 Jun; 104(6):1215-1228. PubMed ID: 31517783
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Access to direct-acting antivirals for hepatitis C-negative transplant recipients receiving organs from hepatitis C-viremic donors.
    Bova S; Cameron A; Durand C; Katzianer J; LeGrand M; Boyer L; Glorioso J; Toman LP
    Am J Health Syst Pharm; 2022 Jan; 79(3):173-178. PubMed ID: 33987658
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Short-term outcomes of deceased donor renal transplants of HCV uninfected recipients from HCV seropositive nonviremic donors and viremic donors in the era of direct-acting antivirals.
    La Hoz RM; Sandıkçı B; Ariyamuthu VK; Tanriover B
    Am J Transplant; 2019 Nov; 19(11):3058-3070. PubMed ID: 31207073
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Utilization of hepatitis C virus-positive donors in kidney transplantation.
    Shetty A; Ariyamuthu VK; Gungor AB; Tanriover B
    Curr Opin Organ Transplant; 2023 Feb; 28(1):22-28. PubMed ID: 36227758
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Liver, simultaneous liver-kidney, and kidney transplantation from hepatitis C-positive donors in hepatitis C-negative recipients: A single-center study.
    Crismale JF; Khalid M; Bhansali A; De Boccardo G; Khaim R; Florman SS; Shapiro R; Schiano TD
    Clin Transplant; 2020 Jan; 34(1):e13761. PubMed ID: 31808193
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hepatitis C and heart transplantation: An update.
    Nunez M; Kelkar AA
    Clin Transplant; 2023 Oct; 37(10):e15111. PubMed ID: 37650430
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cost-effectiveness of Using Kidneys From HCV-Viremic Donors for Transplantation Into HCV-Uninfected Recipients.
    Eckman MH; Woodle ES; Thakar CV; Alloway RR; Sherman KE
    Am J Kidney Dis; 2020 Jun; 75(6):857-867. PubMed ID: 32081494
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Multicenter Study to Transplant Hepatitis C-Infected Kidneys (MYTHIC): An Open-Label Study of Combined Glecaprevir and Pibrentasvir to Treat Recipients of Transplanted Kidneys from Deceased Donors with Hepatitis C Virus Infection.
    Sise ME; Goldberg DS; Kort JJ; Schaubel DE; Alloway RR; Durand CM; Fontana RJ; Brown RS; Friedewald JJ; Prenner S; Landis JR; Fernando M; Phillips CC; Woodle ES; Rike-Shields A; Sherman KE; Elias N; Williams WW; Gustafson JL; Desai NM; Barnaba B; Norman SP; Doshi M; Sultan ST; Aull MJ; Levitsky J; Belshe DS; Chung RT; Reese PP
    J Am Soc Nephrol; 2020 Nov; 31(11):2678-2687. PubMed ID: 32843477
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transplantation of kidneys from hepatitis C-infected donors to hepatitis C-negative recipients: Single center experience.
    Molnar MZ; Nair S; Cseprekal O; Yazawa M; Talwar M; Balaraman V; Podila PSB; Mas V; Maluf D; Helmick RA; Campos L; Nezakatgoo N; Eymard C; Horton P; Verma R; Jenkins AH; Handley CR; Snyder HS; Cummings C; Agbim UA; Maliakkal B; Satapathy SK; Eason JD
    Am J Transplant; 2019 Nov; 19(11):3046-3057. PubMed ID: 31306549
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Liver and Kidney Recipient Selection of Hepatitis C Virus Viremic Donors: Meeting Consensus Report From the 2019 Controversies in Transplantation.
    Burton JR; Terrault NA; Goldberg DS; Bloom RD; Gilroy R; Heimbach JK; Brown RS; Everson GT; Rubin E; Wiesner R; Pomfret EA
    Transplantation; 2020 Mar; 104(3):476-481. PubMed ID: 31634329
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Control of replication of hepatitis B and C virus improves patient and graft survival in kidney transplantation.
    Fontaine H; Alric L; Labreuche J; Legendre B; Louvet A; Antoine C; Legendre CM; Hazzan M; Kamar N; Dharancy S; Pol S; Duhamel A; Mathurin P
    J Hepatol; 2019 May; 70(5):831-838. PubMed ID: 30879789
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Transplantation of Kidneys From Hepatitis C Virus-Infected Donors to Hepatitis C Virus-Negative Recipients: One-Year Kidney Allograft Outcomes.
    Molnar MZ; Azhar A; Tsujita M; Talwar M; Balaraman V; Bhalla A; Podila PSB; Kothadia J; Agbim UA; Maliakkal B; Satapathy SK; Kovesdy CP; Nair S; Eason JD
    Am J Kidney Dis; 2021 May; 77(5):739-747.e1. PubMed ID: 33333148
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Use of Organs From Hepatitis C Virus-Positive Donors for Uninfected Recipients: A Potential Cost-Effective Approach to Save Lives?
    Trotter PB; Summers DM; Ushiro-Lumb I; Robb M; Bradley JA; Powell J; Watson CJE; Neuberger J
    Transplantation; 2018 Apr; 102(4):664-672. PubMed ID: 29166338
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The association of donor hepatitis C virus infection with 3-year kidney transplant outcomes in the era of direct-acting antiviral medications.
    Sutcliffe S; Ji M; Chang SH; Stewart D; Axelrod DA; Lentine KL; Wellen J; Alrata L; Gupta G; Alhamad T
    Am J Transplant; 2023 May; 23(5):629-635. PubMed ID: 37130619
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical outcomes of heart transplantation using hepatitis c-viremic donors: A systematic review with meta-analysis.
    Villegas-Galaviz J; Anderson E; Guglin M
    J Heart Lung Transplant; 2022 Apr; 41(4):538-549. PubMed ID: 35153130
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Use of Hepatitis C Virus-Positive Organs in Hepatitis C Virus-Negative Recipients.
    Kuntzen C; Bagha Z
    Clin Liver Dis; 2022 May; 26(2):291-312. PubMed ID: 35487612
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Survey of Clinician Opinions on Kidney Transplantation from Hepatitis C Virus Positive Donors: Identifying and Overcoming Barriers.
    Lentine KL; Peipert JD; Alhamad T; Caliskan Y; Concepcion BP; Forbes R; Schnitzler M; Chang SH; Cooper M; Bloom RD; Mannon RB; Axelrod DA
    Kidney360; 2020 Nov; 1(11):1291-1299. PubMed ID: 33251523
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.